Skip to main content

Table 2 Comparison between patients who received an appropriate initial antimicrobial therapy against Enterococcus species isolated from peritoneal sample versus patients who did not and between the groups E. faecalis alone and Enterococcus other than E. faecalis alone. Results expressed in numbers (percentages) apart from *median and interquartile interval [1st–3rd]. **Diagnosed within 48 h preceding IAI diagnosis. IAI intraabdominal infections

From: Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care—an analysis of the OUTCOMEREA database

Variables

Initial antimicrobial therapy inactive against Enterococcus (n = 18)

Initial antimicrobial therapy active against Enterococcus (n = 58)

p

Enterococcus other than E. faecalis alone (n = 34)

E. faecalis alone without other Enterococcus species (n = 42)

p

Antimicrobial therapy use < 3 months prior to IAI

9 (50.0)

34 (58.6)

0.519

26 (76.5)

17 (40.5)

0.002

Third-generation cephalosporin use < 3 months prior to IAI

6 (33.3)

7 (12.1)

0.036

9 (26.5)

4 (9.5)

0.051

Hospital admission-IAI time*

4 [2–7]

10 [3–22]

0.016

10 [3–24]

6 [2–13]

0.104

ICU admission-IAI time*

1 [1–4]

1 [1–5]

0.622

2 [1–7]

1 [1–1]

0.024

IAI diagnosis-surgery time*

0 [0–0]

0 [0–0]

0.728

0 [0–0]

0 [0–0]

0.986

Postoperative IAI

7 (38.9)

18 (79.3)

0.001

23 (67.6)

30 (71.4)

0.721

ICU-acquired IAI

8 (44.4)

16 (27.6)

0.179

15 (44.1)

9 (21.4)

0.034

SAPS on day 0*

56.5 [39–63]

45.5 [37–55]

0.029

50.0 [39–60]

45.5 [36–54]

0.051

Day 0 vasopressor use

14 (77.8)

40 (69.0)

0.471

27 (79.4)

27 (64.3)

0.148

Septic shock at diagnosis

15 (83.3)

38 (65.5)

0.151

26 (76.5)

27 (64.3)

0.250

Pneumonia**

1 (5.6)

1 (1.7)

0.375

1 (2.9)

1 (2.4)

0.879

Other bacteremia**

2 (11.1)

4 (6.9)

0.562

2 (5.9)

4 (9.5)

0.558

Catheter-related bloodstream infection**

0 (0)

3 (5.2)

0.151

1 (2.9)

2 (4.8)

0.685

Adequate initial antimicrobial therapy against other germs

14 (77.8)

50 (86.2)

0.392

28 (82.4)

36 (85.7)

0.689

Inadequate initial antimicrobial therapy against identified Enterococcus

18 (100)

0 (0)

< 0.001

22 (64.7)

36 (85.7)

0.032

Vancomycin in initial antimicrobial regimen

1 (5.6)

22 (37.9)

0.009

   

E. faecium isolated in peritoneal sample

11 (61.1)

17 (29.3)

0.015

   

E. faecalis isolated in peritoneal sample

8 (44.4)

38 (65.5)

0.110

   

Other Enterococcus isolated in peritoneal sample

2 (11.1)

7 (12.1)

0.913

   

Day 30 surgical complications

8 (44.4)

27 (46.6)

0.875

15 (44.1)

20 (47.6)

0.761

Day 30 relaparotomy or percutaneous drainage

4 (22.2)

19 (32.8)

0.395

7 (20.6)

16 (38.1)

0.099

Day 30 infectious complications

7 (38.9)

17 (29.3)

0.445

12 (35.3)

12 (28.6)

0.531

Day 30 mortality

7 (38.9)

10 (17.2)

0.054

12 (35.3)

5 (11.9)

0.015